| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 14.751 | 0 | 0 | 0 | 0 | 1.832 |
| Total Income - EUR | - | - | - | - | 14.751 | 0 | 0 | 0 | 0 | 1.832 |
| Total Expenses - EUR | - | - | - | - | 335 | 329 | 75 | 158 | 0 | 630 |
| Gross Profit/Loss - EUR | - | - | - | - | 14.416 | -329 | -75 | -158 | 0 | 1.201 |
| Net Profit/Loss - EUR | - | - | - | - | 13.974 | -329 | -75 | -158 | 0 | 1.013 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cs Oncology S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 4 | 0 | 0 | 0 | 0 | 649 |
| Current Assets | - | - | - | - | 14.140 | 24 | -13 | -13 | -13 | 291 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 5.937 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | 8.204 | 24 | -13 | -13 | -13 | 291 |
| Shareholders Funds | - | - | - | - | 14.016 | -280 | -348 | -508 | -506 | 510 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 129 | 304 | 336 | 495 | 493 | 430 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cs Oncology S.r.l.